Precision BioSciences
在场
Precision BioSciences 是一家在股票代码 DTIL (US) 下上市的公司。
高管
查看带有其 19 名主要高管的组织结构图
Precision BioSciences 搜索最多的简介
- Michael Amoroso, Director, President and Chief Executive Officer
- Stanley Frankel, Director
- Sam Wadsworth, Director
高管在Precision BioSciences变化
- Naresh Tanna 曾任 Chief of Staff, 现升职为 Vice President of Investor Relations (新闻发布的2024二月14号).
创建提醒
跟踪 Precision BioSciences 的高管变动
生物技术
Precision BioSciences 拥有 2,276 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (公布2024四月16号).
- Nurix Therapeutics 刚刚宣布为 175 筹款数百万美元。 (公布2024四月13号).
生物技术 行业的其他推荐联系人
消息
Precision BioSciences 的最新新闻稿
- Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October | Precision BioSciences
- Precision BioSciences to Present at Upcoming Virtual Investor Conferences in September | Precision BioSciences
- Precision BioSciences Reports Second Quarter 2020 Financial Results and Provides Business Update | Precision BioSciences
- Elo Life Systems Announces Strategic Partnership with Dole Food Company with the Goal of Saving the Cavendish Banana | Precision BioSciences
- Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program | Precision BioSciences
- Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update | Precision Biosciences
- Precision BioSciences to Report First Quarter 2020 Financial Results and Present at Bank of America Securities Health Care Conference 2020 | Precision Biosciences
- Precision BioSciences Announces Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting | Precision Biosciences
- Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources | Precision Biosciences
- Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A for Relapsed/Refractory NHL, CLL, and SLL | Precision Biosciences
- View more press releases Close
通过电子邮件
